These findings suggest that HS itself may contribute to metabolic dysfunction through the action of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-17, and interferon-γ which are implicated in both insulin resistance and HS pathogenesis[9]. This evidence concerns the gene IL17A and histiocytic sarcoma.